Unitree shares fell 45% after surging more than 5x in their August 19 Shanghai debut, cutting its valuation from $66B to $36B, raising robotics bubble concerns (Reuters)

China's Unitree, a leading humanoid robot manufacturer, experienced a 45% decline in shares following a significant fivefold increase during its Shanghai IPO debut, raising concerns about a potential bubble, retail investor losses, and issues with the initial public offering (IPO) process. The rapid valuation shift, from $66 billion to a $30 billion decrease, prompted speculation about whether the excitement surrounding AI and robotics had outpaced tangible fundamentals.

The post-listing sell-off also led to discussions about China's IPO mechanism, with some analysts suggesting it may distort prices.

Unitree, a key producer of quadruped and humanoid robots, steadied its shares after three days of losses, reducing the slump to 45% since its debut last Wednesday. This decline could serve as a cautionary tale for other Chinese tech firms eyeing IPO opportunities during the government's push for self-sufficiency. The listing also underscores the challenges authorities face in stimulating strategic industries without triggering market manias.

Unitree's initial public offering was anticipated to set the precedent for a wave of domestic competitors. Investors were enticed by the narrative of a technological revolution, but Dong Baozhen, chairman of Beijing's asset manager Lingtong Shengtai, cautioned that all bubbles inevitably burst. The company's debut performance, driven by enthusiasm rather than solid prospects, mirrored the broader tech sector's prominence in China over the past year as the nation's rivalry with the U.S. intensified.

Despite early signs of a profit downturn in Unitree's first half of 2026, the company's robots have garnered attention for their ability to run, dance, and even perform martial arts. However, their commercial applications have been limited. Abraham Zhang, chairman of venture capital firm China Europe Capital, attributed Unitree's IPO performance to investors' desire to profit from the shares before dumping them at inflated prices.

China's IPO system has allowed major stakeholders to reap substantial gains while shifting risks to retail investors in secondary markets, according to venture capitalist Zhang. Regulatory paternalism and the absence of short-selling have contributed to overpriced listings facing minimal pushback from authorities. The IPO of Unitree and memory chipmaker CXMT, which surged 466% in its debut, attracted investors due to perceived state support.

Hedge fund manager Yuan Yuwei attributed the frenzy to a lack of compelling Chinese IPO options, stating that investors were chasing high-growth potential amidst limited opportunities. Despite regulators' strict oversight, only 21 companies went public in Shanghai during the first seven months of the year, compared to 104 in Hong Kong.

Fund manager Gao Xingkun of China Southern Asset Management Co. argued that investors should exercise patience and adopt a long-term perspective, emphasizing that early-stage robot makers may struggle with commercial orders.

Dong Baozhen noted the stark disparity between Unitree's IPO price and its post-listing performance, arguing that one must be incorrect, with the latter likely mispriced. He attributed the gap to a mispriced IPO, suggesting that debut performance serves as a gauge of market sentiment and that exuberant moods can give rise to bubbles. Hedge fund manager Yuan further criticized the practice of pump-and-dump schemes, which have become possible due to restricted short-selling in China.

A retail investor who suffered losses on Unitree expressed support for Chinese innovation but lamented the rapid concentration of wealth at the expense of retail investors, likening the situation to a rip-off for those who invested early. Zhang, the venture capitalist, echoed these sentiments, warning that the Unitree listing is not an isolated incident and that similar capital dramas are likely to recur in the Chinese market.